Prince of Wales Hospital Researcher Details Findings in Psychiatry (Time for a change to clozapine haematological monitoring).

A new report from researchers at Prince of Wales Hospital in Sydney, Australia critiques the current guidelines for monitoring the blood of patients taking the antipsychotic medication clozapine. The researchers argue that the current guidelines are not consistent with the evidence and that the risks of clozapine-induced neutropenia and agranulocytosis are rare and low. They suggest potential modifications to the guidelines, such as changing thresholds for patients with benign ethnic neutropenia and reducing the frequency of monitoring after two years of treatment. The full article can be accessed for free through the provided link. [Extracted from the article]